Literature DB >> 4952249

Morphology of the intestinal arterioles in chronic human hypertension.

D Short.   

Abstract

Entities:  

Mesh：

Year:  1966        PMID： 4952249      PMCID： PMC459059          DOI： 10.1136/hrt.28.2.184

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  7 in total

1.  A vascular abnormality in hypertension. A study of blood flow in the forearm.

Authors:  J CONWAY
Journal:  Circulation       Date:  1963-04       Impact factor: 29.690

2.  Architecture of small arteries during vasoconstriction.

Authors:  R L VAN CITTERS; B M WAGNER; R F RUSHMER
Journal:  Circ Res       Date:  1962-04       Impact factor: 17.367

3.  Arterial measurements in the interpretation of cardiomegaly at necropsy: cardiac hypertrophy and myocardial infarction.

Authors:  A M BARRETT
Journal:  J Pathol Bacteriol       Date:  1963-07

4.  Persistence of abnormally high vascular tone in vessels of the finger after digital nerve block in patients with chronic high blood pressure.

Authors:  P GASKELL; A DIOSY
Journal:  Circ Res       Date:  1959-11       Impact factor: 17.367

5.  Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance.

Authors:  B FOLKOW; G GRIMBY; O THULESIUS
Journal:  Acta Physiol Scand       Date:  1958-12-15

6.  The arteries of the small intestine in systemic hypertension.

Authors:  D S SHORT; A D THOMSON
Journal:  J Pathol Bacteriol       Date:  1959-10

7.  The arterial bed of the lung in pulmonary hypertension.

Authors:  D S SHORT
Journal:  Lancet       Date:  1957-07-06       Impact factor: 79.321
  7 in total
  10 in total

1.  Assessment of myocardial vasculature in chronic alcoholics without established cardiomyopathy.

Authors:  A N Ahmed; R A Elton; A Busuttil
Journal:  Int J Legal Med       Date:  1996       Impact factor: 2.686

Review 2.  Diverticular disease of the colon: a 1968 view.

Authors:  I Williams
Journal:  Gut       Date:  1968-10       Impact factor: 23.059

Review 3.  Changes to the vascular system resulting from hypertension and their effects on response to therapy.

Authors:  M J Mulvany
Journal:  Drugs       Date:  1990       Impact factor: 9.546

4.  Two variants of nephrosclerosis separately related to age and blood pressure.

Authors:  R E Tracy; M Velez-Duran; T Heigle; M C Oalmann
Journal:  Am J Pathol       Date:  1988-05       Impact factor: 4.307

5.  Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension.

Authors:  B Egan; R Panis; A Hinderliter; N Schork; S Julius
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

6.  Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats.

Authors:  Paulo W Pires; Curt T Rogers; Jonathon L McClain; Hannah S Garver; Gregory D Fink; Anne M Dorrance
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-06       Impact factor: 4.733

7.  Vascular remodelling in intramyocardial resistance vessels in hypertensive human cardiac transplant recipients.

Authors:  J T Jenkins; J J Boyle; I C McKay; D Richens; A R McPhaden; G B Lindop
Journal:  Heart       Date:  1997-04       Impact factor: 5.994

8.  Significance of microvascular remodelling for the vascular flow reserve in hypertension.

Authors:  Jens Christian Brings Jacobsen; Morten Sonne Hornbech; Niels-Henrik Holstein-Rathlou
Journal:  Interface Focus       Date:  2010-12-01       Impact factor: 3.906

9.  Hypertension and nephrosclerosis: a reappraisal and a new theory of renal ischemia.

Authors:  S Moore
Journal:  Can Med Assoc J       Date:  1967-02-25       Impact factor: 8.262

10.  Simvastatin attenuated rat thoracic aorta remodeling by decreasing ROCK2‑mediated CyPA secretion and CD147‑ERK1/2‑cyclin pathway.

Authors:  Fu-Cai Tang; Hong-Yan Wang; Ming-Ming Ma; Tian-Wang Guan; Long Pan; Dun-Chen Yao; Ya-Lan Chen; Sheng-Jie Li; Hang Yang; Xiao-Qin Zhu; Yong-Sheng Tu
Journal:  Mol Med Rep       Date:  2017-09-27       Impact factor: 2.952
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.